Bruno ROBERT

City:

Montpellier

Country:

France

Published Applications:

Last publication date:

2025-06-19

Top Assignees for applications by Bruno ROBERT

The entities that hold a legal rights for patent applications filed by inventor ROBERT Bruno:

Institut Regional du Cancer de Montpellier 4 Montpellier, France
INSERM INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) 4 Paris, France
Université De Montpellier 4 Montpellier, France
OriBase Pharma 2 Montpellier Cedex 4, France
UNIVERSITE DE MONTPELLIER 1 2 Montpellier Cedex 6, France
Institut Regional du Cancer de Montpellier-Val d' Aurelle 1 Montpellier Cedex, France
SORBONNE UNIVERSITE 1 Paris, France
UNIVERSITE De Montpellier 1 1 , France
INSERM (Institut National de la Santé et de la Recherche Médicale) 1 , France
UNIVERSITE DE LILLE 1 Paris, France
Universite Paris Diderot-Paris 7 1 Paris, France
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) 1 Paris, France
INSERM (Institut National de la Santa et de la Recherche Medicale) 1 Paris, France
Institut Regional du Cancer de Montpellier-Val d' Aurelle 1 Montpellier Cedex 5, France
UNIVERSITE DE MONTPELLIER 1 1 MONTPELLIER CEDEX, France
ORIBASE PHARMA 1 Montpellier Cedex, France
Centre National de la Recherche Scientifique (CNRS 1 Paris, France
institut pasteur de lille 1 Lille, France
ORIBASE Pharma 1 , France
INSTITUT Regional Du Cancer De Montpellier-Val D'Aurelle 1 , France
Institut Regional du Cancer de Montpellier-Val d'Aurelle 1 Montpellier Cedex 5, France

Recent patent applications by ROBERT Bruno

Bruno ROBERT from Montpellier, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-06-19

US20250197476A1

Chemistry; metallurgy

HYBRID MOLECULE COMPRISING AN ANTIBODY FC FRAGMENT AND AT LEAST ONE FIBRIN-DERIVED CITRULLINATED PEPTIDE, AND USES THEREOF

#2 | 2024-09-05

US20240294658A1

Chemistry; metallurgy

HYBRID MOLECULE COMPRISING A FIBRIN-DERIVED CITRULLINATED PEPTIDE AND AN ANTIBODY OR ANTIBODY FRAGMENT WHICH BINDS TO CD38 AND/OR CD138, AND USES THEREOF

#3 | 2023-01-05

US20230002497A1

Chemistry; metallurgy

ANTIBODIES SPECIFIC FOR IL20-RB AND USES THEREOF FOR THE TREATMENT OF ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

#4 | 2022-10-13

US20220324962A1

Chemistry; metallurgy

ANTI-MÜLLERIAN INHIBITING SUBSTANCE ANTIBODIES AND USES THEREOF

#5 | 2019-08-22

US20190256595A1

Chemistry; metallurgy

Monoclonal antibodies binding to the CD160 transmembrane isoform

#6 | 2018-02-01

US20180030135A1

Chemistry; metallurgy

HUMAN MONOCLONAL ANTIBODIES AGAINST OREXIN RECEPTOR TYPE 1

#7 | 2018-01-04

US20180002421A1

Chemistry; metallurgy

Human monoclonal antibodies against orexin receptor type 1

#8 | 2017-11-30

US20170340734A1

Human necessities

Human monoclonal antibodies against AXL

#9 | 2014-10-09

US20140302041A1

Chemistry; metallurgy

Anti-Axl antibodies and uses thereof

#10 | 2014-08-14

US20140227283A1

Chemistry; metallurgy

Anti-Axl antibodies and uses thereof

InventorID:

2104324 ⎘